Celcuity Inc. - CELC
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 24, 2026 | SCHEDULE 13D/A | — | 4.99% | — | View |
| Mar 09, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Feb 17, 2026 | SCHEDULE 13G | Avoro Capital Advisors LLC | 6.72% | 3,111,111 | View |
| Feb 17, 2026 | SCHEDULE 13G | Behzad Aghazadeh | 6.72% | 3,111,111 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Perceptive Advisors LLC | 6.8% | 3,160,200 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Joseph Edelman | 6.8% | 3,160,200 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 6.8% | 3,160,200 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Private Equity Fund II, L.P. | 0.3% | 142,118 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Private Equity GP II, LLC | 0.3% | 142,118 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus PE GP II, LLC | 0.3% | 142,118 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital Master Fund, L.P. | 3.6% | 1,664,756 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital, LLC | 3.6% | 1,664,756 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital Group, LLC | 3.6% | 1,664,756 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital Management, L.P. | 3.9% | 1,806,874 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus GP, LLC | 3.9% | 1,806,874 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Guy Levy | 3.9% | 1,808,258 | View |
| Jan 16, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND L P | 0.8% | 340,278 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BVF I GP LLC | 0.8% | 340,278 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND II LP | 0.6% | 268,775 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BVF II GP LLC | 0.6% | 268,775 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Biotechnology Value Trading Fund OS LP | 0.09% | 36,270 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BVF Partners OS Ltd. | 0.09% | 36,270 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BVF GP HOLDINGS LLC | 1.4% | 609,053 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BVF PARTNERS L P/IL | 1.6% | 658,421 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BVF INC/IL | 1.6% | 658,421 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | LAMPERT MARK N | 1.6% | 658,421 | View |
| Nov 13, 2025 | SCHEDULE 13G/A | Brian F. Sullivan | 9.1% | 4,013,203 | View |
| Nov 13, 2025 | SCHEDULE 13G/A | Lance G. Laing | 3.6% | 1,568,766 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.